Argent Trust Co’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $488K | Buy |
2,476
+129
| +5% | +$24.9K | 0.02% | 482 |
|
|
2025
Q4 | $432K | Sell |
2,347
-287
| -11% | -$50.3K | 0.01% | 496 |
|
|
2025
Q3 | $404K | Sell |
2,634
-383
| -13% | -$58K | 0.01% | 500 |
|
|
2025
Q2 | $422K | Sell |
3,017
-245
| -8% | -$34.3K | 0.02% | 487 |
|
|
2025
Q1 | $480K | Sell |
3,262
-14
| -0.4% | -$2.03K | 0.02% | 442 |
|
|
2024
Q4 | $429K | Hold |
3,276
| – | – | 0.02% | 461 |
|
|
2024
Q3 | $510K | Sell |
3,276
-292
| -8% | -$47.1K | 0.02% | 420 |
|
|
2024
Q2 | $557K | Buy |
3,568
+309
| +9% | +$46.5K | 0.02% | 394 |
|
|
2024
Q1 | $442K | Buy |
3,259
+256
| +9% | +$33.9K | 0.02% | 434 |
|
|
2023
Q4 | $405K | Hold |
3,003
| – | – | 0.02% | 438 |
|
|
2023
Q3 | $407K | Buy |
3,003
+65
| +2% | +$8.88K | 0.02% | 425 |
|
|
2023
Q2 | $420K | Hold |
2,938
| – | – | 0.02% | 427 |
|
|
2023
Q1 | $408K | Buy |
2,938
+31
| +1% | +$4.17K | 0.03% | 377 |
|
|
2022
Q4 | $394K | Sell |
2,907
-51
| -2% | -$6.4K | 0.03% | 377 |
|
|
2022
Q3 | $324K | Sell |
2,958
-62
| -2% | -$7.87K | 0.02% | 412 |
|
|
2022
Q2 | $399K | Sell |
3,020
-25
| -0.8% | -$3.28K | 0.03% | 379 |
|
|
2022
Q1 | $404K | Buy |
3,045
+491
| +19% | +$58.9K | 0.02% | 390 |
|
|
2021
Q4 | $297K | Sell |
2,554
-185
| -7% | -$21.8K | 0.02% | 472 |
|
|
2021
Q3 | $329K | Sell |
2,739
-2
| -0.1% | -$233 | 0.02% | 430 |
|
|
2021
Q2 | $329K | Buy |
2,741
+567
| +26% | +$62.2K | 0.02% | 426 |
|
|
2021
Q1 | $217K | Sell |
2,174
-69
| -3% | -$6.94K | 0.02% | 465 |
|
|
2020
Q4 | $224K | Sell |
2,243
-54
| -2% | -$5.72K | 0.02% | 440 |
|
|
2020
Q3 | $252K | Buy |
+2,297
| New | +$255K | 0.02% | 396 |
|
|
2019
Q1 | – | Sell |
-6,189
| Closed | -$470K | – | 428 |
|
|
2018
Q4 | $470K | Buy |
6,189
+3,507
| +131% | +$274K | 0.06% | 273 |
|
|
2018
Q3 | $212K | Sell |
2,682
-738
| -22% | -$55.8K | 0.02% | 411 |
|
|
2018
Q2 | $239K | Buy |
+3,420
| New | +$246K | 0.03% | 383 |
|
|
2017
Q3 | – | Sell |
-5,221
| Closed | -$356K | – | 266 |
|
|
2017
Q2 | $356K | Sell |
5,221
-3,846
| -42% | -$251K | 0.15% | 185 |
|
|
2017
Q1 | $565K | Buy |
9,067
+3,455
| +62% | +$201K | 0.23% | 133 |
|
|
2016
Q4 | $306K | Buy |
5,612
+895
| +19% | +$50.8K | 0.14% | 193 |
|
|
2016
Q3 | $310K | Sell |
4,717
-1,063
| -18% | -$69.5K | 0.13% | 195 |
|
|
2016
Q2 | $349K | Sell |
5,780
-910
| -14% | -$52.9K | 0.15% | 177 |
|
|
2016
Q1 | $377K | Buy |
6,690
+18
| +0.3% | +$1.08K | 0.18% | 162 |
|
|
2015
Q4 | $453K | Buy |
6,672
+339
| +5% | +$22.2K | 0.23% | 142 |
|
|
2015
Q3 | $403K | Buy |
6,333
+506
| +9% | +$33.3K | 0.23% | 139 |
|
|
2015
Q2 | $371K | Buy |
5,827
+505
| +9% | +$34.6K | 0.19% | 156 |
|
|
2015
Q1 | $364K | Hold |
5,322
| – | – | 0.18% | 164 |
|
|
2014
Q4 | $375K | Buy |
+5,322
| New | +$381K | 0.23% | 135 |
|
Other funds holding AZN
IA
VCM
VAM
Argent Trust Co's AZN Position: Q1 2026 in Review
Argent Trust Co increased its AstraZeneca (AZN) stake by 5.5% in Q1 2026, buying an estimated $24.9K and bringing the position to 2,476 shares worth $488K. The position accounts for 0.02% of the portfolio, ranked #482.
Argent Trust Co first reported a position in AZN in Q4 2014 and has held it in 37 quarters since. The position peaked at $565K in Q1 2017. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Argent Trust Co held 2,476 shares of AstraZeneca worth $488K as of Q1 2026.
- Argent Trust Co bought 129 AstraZeneca shares in Q1 2026, an estimated $24.9K.
- AstraZeneca made up 0.02% of Argent Trust Co's portfolio in Q1 2026, its #482 holding.
- Argent Trust Co first reported a position in AstraZeneca in Q4 2014 and has held it in 37 quarters since.
- Argent Trust Co's AstraZeneca position peaked at $565K in Q1 2017.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.